Kevin M. Picardat

Array ( [id] => 6633736 [patent_doc_number] => 20100311950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'SOY PROTEIN GEL AND METHOD OF PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/734547 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12542 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311950.pdf [firstpage_image] =>[orig_patent_app_number] => 12734547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379742 [patent_doc_number] => 20090191581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'CELL-PERMEABLE FLUORESCENT PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/245546 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7368 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191581.pdf [firstpage_image] =>[orig_patent_app_number] => 12245546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629161 [patent_doc_number] => 08008044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Animal product free media and processes for obtaining a botulinum toxin' [patent_app_type] => utility [patent_app_number] => 12/234537 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008044.pdf [firstpage_image] =>[orig_patent_app_number] => 12234537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834345 [patent_doc_number] => 08450100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Collagen peptide having immune-enhancing activity from Cyanea nozakii and preparation method and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/993819 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2967 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429144 [patent_doc_number] => 20090088454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'ANTI-CANCER COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/212604 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7281 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088454.pdf [firstpage_image] =>[orig_patent_app_number] => 12212604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416912 [patent_doc_number] => 20090042799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'CLOSTRIDIAL TOXIN DERIVATIVES AND METHODS FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/211594 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13135 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042799.pdf [firstpage_image] =>[orig_patent_app_number] => 12211594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725528 [patent_doc_number] => 08404644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Agents with angiogenic and wound healing activity' [patent_app_type] => utility [patent_app_number] => 12/676295 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 23673 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337838 [patent_doc_number] => 20090054302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Methods and Preparations For Curing Clinically Ill Patients' [patent_app_type] => utility [patent_app_number] => 12/196447 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11923 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054302.pdf [firstpage_image] =>[orig_patent_app_number] => 12196447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773623 [patent_doc_number] => 08119370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Activatable recombinant neurotoxins' [patent_app_type] => utility [patent_app_number] => 12/196381 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 15898 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119370.pdf [firstpage_image] =>[orig_patent_app_number] => 12196381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522201 [patent_doc_number] => 20090030182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS' [patent_app_type] => utility [patent_app_number] => 12/196658 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15886 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030182.pdf [firstpage_image] =>[orig_patent_app_number] => 12196658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522207 [patent_doc_number] => 20090030188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS' [patent_app_type] => utility [patent_app_number] => 12/195985 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15891 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030188.pdf [firstpage_image] =>[orig_patent_app_number] => 12195985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539162 [patent_doc_number] => 20090220967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Systemic Carnitine Deficiency Gene and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/193654 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7279 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220967.pdf [firstpage_image] =>[orig_patent_app_number] => 12193654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508523 [patent_doc_number] => 20090081730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS' [patent_app_type] => utility [patent_app_number] => 12/193527 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16673 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081730.pdf [firstpage_image] =>[orig_patent_app_number] => 12193527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8409964 [patent_doc_number] => 08273358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Activatable clostridial toxins' [patent_app_type] => utility [patent_app_number] => 12/192900 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 33 [patent_no_of_words] => 75469 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12192900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291171 [patent_doc_number] => 20090023901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Degradable Clostridial Toxins' [patent_app_type] => utility [patent_app_number] => 12/192905 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 63553 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023901.pdf [firstpage_image] =>[orig_patent_app_number] => 12192905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7976727 [patent_doc_number] => 08071110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Activatable clostridial toxins' [patent_app_type] => utility [patent_app_number] => 12/192546 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 33 [patent_no_of_words] => 86496 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071110.pdf [firstpage_image] =>[orig_patent_app_number] => 12192546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349952 [patent_doc_number] => 20090005313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS' [patent_app_type] => utility [patent_app_number] => 12/192419 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 100957 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005313.pdf [firstpage_image] =>[orig_patent_app_number] => 12192419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472507 [patent_doc_number] => 20100041098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'MODIFIED CLOSTRIDIAL TOXINS WITH ALTERED TARGETING CAPABILITIES FOR CLOSTRIDIAL TOXIN TARGET CELLS' [patent_app_type] => utility [patent_app_number] => 12/192934 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 119232 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041098.pdf [firstpage_image] =>[orig_patent_app_number] => 12192934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310800 [patent_doc_number] => 20090018081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS' [patent_app_type] => utility [patent_app_number] => 12/192854 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 96787 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018081.pdf [firstpage_image] =>[orig_patent_app_number] => 12192854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348816 [patent_doc_number] => 20090004177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Combination Treatment with t-PA Variant and Low Molecular Weight Heparin' [patent_app_type] => utility [patent_app_number] => 12/185588 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11261 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004177.pdf [firstpage_image] =>[orig_patent_app_number] => 12185588 [rel_patent_id] =>[rel_patent_doc_number] =>)